Monday, January 25, 2021
Home Clinical Research What is Phase-III Clinical Trial?

What is Phase-III Clinical Trial?

“Phase III trials are conducted to confirm and expand on the safety and effectiveness results from Phase I and II trials, to compare the drug to the standard therapies for the disease or condition being studied, and to evaluate the overall risks and benefits of the drug.

Phase III studies are commonly randomized multicenter controlled trials on large patient populations (300–3,000 or more depending on the disease/medical condition studied) and are meant to be the definitive measure of how successful the medication is relative to the existing ‘gold standard’ treatment.

- Advertisement -

Phase III aim is to determine how the new medication performs for the same condition relative to existing drugs.

Before continuing with the experiment, researchers need to show that the drug is at least as safe and successful as the treatment options that exist.

Because of their size and relatively long duration, Phase III trials are the most expensive, time-consuming and difficult trials to design and run, especially in therapies for chronic medical conditions.

Once a drug has proved acceptable after Phase III trials, the trial results are generally combined into a large document containing a comprehensive description of the methods and results of the human and animal studies, manufacturing procedures, formulation details, and shelf life.

This collection of information makes up the “regulatory submission” that is provided for review to the suitable regulatory authoritiesin different countries.

Most drugs undergoing Phase III clinical trials can be marketed under FDA norms with the proper recommendations and guidelines through a New Drug Application (NDA) containing all the manufacturing, preclinical, and clinical data.

In case of any side effects being reported anywhere, the drugs need to be recalled without any delay from the market.”


Please enter your comment!
Please enter your name here

17 − 2 =

Most Popular

What is the process for Submission of Synopsis?

1.1 a. "Prior to submission of a thesis synopsis, a comprehensive assessment of the research work should be carried out by a...

COVAX Announces new agreement, plans for first deliveries

January 22, 2021: COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income...

FDA Approves OPDIVO® with CABOMETYX® as First-line Treatment for advanced Renal Cell Carcinoma

22 Jan 2021:  Bristol Myers Squibb announced that OPDIVO®(nivolumab) 240 mg (injection for intravenous use) every two weeks or 480 mg every four weeks...

FDA granted approval of Cabenuva and Vocabria to ViiV Healthcare for HIV

January 21, 2021: "The U.S. FDA approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human...